Osaic Holdings’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Osaic Holdings’s Portfolio IMPL Stock Details IMPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-575	Closed	-$247	–	7538
2023 Q3	$247	Hold	575	–	–	﹤0.01%	7117
2023 Q2	$730	Hold	575	–	–	﹤0.01%	6965
2023 Q1	$805	Hold	575	–	–	﹤0.01%	7023
2022 Q4	$2K	Hold	575	–	–	﹤0.01%	6750
2022 Q3	$3K	Hold	575	–	–	﹤0.01%	6700
2022 Q2	$5K	Buy	+575	New	+$4.2K	﹤0.01%	6524

Other funds holding IMPL

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Osaic Holdings's IMPL Position: Q4 2023 in Review

Osaic Holdings sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q4 2023, closing a stake of 575 shares — an estimated $247 sold.

Osaic Holdings first reported a position in IMPL in Q2 2022 and held it in 6 quarters. The position peaked at $5K in Q2 2022. 2 funds tracked by Wall St. Rank hold IMPL as of Q4 2023.

Osaic Holdings reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Osaic Holdings sold 575 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2023, an estimated $247.
Osaic Holdings first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Osaic Holdings's Impel Pharmaceuticals Inc. Common Stock position peaked at $5K in Q2 2022.
2 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.